BioSpace News Archive

The complex nature of heterogeneous tissues has encouraged the development of several tools for the analysis of single cell.

CorDx, a global leader in the development, manufacturing, and distribution of diagnostics and medical devices, recently received EN ISO 13485 certification for its U.S.-based facilities.

The healthcare financial analytics market is prognosticated to observe steady growth during the forecast period of 2021-2031.

The referral management market is expected to observe extensive growth during the forecast period of 2021-2031.

Surge in initiatives by several government bodies to reduce the healthcare costs is projected to translate into extensive growth prospects for companies operating in the global long-term care software market during the forecast period between 2021 and 2031.

Regulatory News: Median Technologies announced that the Company will be participating in the 2022 ESMO Congress, to be held in Paris, France, September 9-13.

InterVenn Biosciences, the leader in glycoproteomics, today announced Aldo Carrascoso, Co-Founder and CEO, and Erwin Estigarribia, COO, will present at the 20th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2022 in New York, NY.

Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced that management will be participating at the upcoming H.C. Wainwright’s 24th Annual Global Investment Conference taking place on September 12-14, 2022.

eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced that the Company will present and host 1x1 meetings at the upcoming H.C. Wainwright 24th Annual Global Investment Conference.

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, announced that Chairman and Chief Executive Officer Al Altomari and Vice President of Marketing Amy Welsh will present at the H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022 in New York, NY.